An NR2B-dependent decrease in the expression of trkB receptors precedes the disappearance of dopaminergic cells in substantia nigra in a rat model of presymptomatic parkinson's disease

Parkinson's Disease

Volumn , Issue , 2012, Pages

  Riquelme, Eduardo ^a   Abarca, Jorge ^a   Campusano, Jorge M ^a   Bustos, Gonzalo ^a,b  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b UNIVERSIDAD SAN SEBASTIÁN   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; IFENPRODIL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; OXIDOPAMINE; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SUBSTANTIA NIGRA PARS COMPACTA;

EID: 84863653246     PISSN: None     EISSN: 20420080     Source Type: Journal    
DOI: 10.1155/2012/129605     Document Type: Article

References (54)

1. Bernheimer H., Birkmayer W., Hornykiewicz O., Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations Journal of the Neurological Sciences 1973 20 4 415 455
2. Bezard E., Dovero S., Prunier C., Ravenscroft P., Chalon S., Guilloteau D., Crossman A. R., Bioulac B., Brotchie J. M., Gross C. E., Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease Journal of Neuroscience 2001 21 17 6853 6861 (Pubitemid 32781128)
3. Kirik D., Rosenblad C., Bjrklund A., Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat Experimental Neurology 1998 152 2 259 277 (Pubitemid 28419264)
4. Morrish P. K., Sawle G. V., Brooks D. J., Clinical and [(18 F)]dopa PET findings in early Parkinson's disease Journal of Neurology Neurosurgery and Psychiatry 1995 59 6 597 600
5. Acheson A. L., Zigmond M. J., Stricker E. M., Compensatory increase in tyrosine hydroxylase activity in rat brain after intraventricular injections of 6-hydroxydopamine Science 1980 207 4430 537 540 (Pubitemid 10141135)
6. Agid Y., Javoy F., Glowinski J., Hyperactivity of remaining dopaminergic neurones after partial destruction of the nigro striatal dopaminergic system in the rat Nature New Biology 1973 245 144 150 151
7. Altar C. A., Marien M. R., Preservation of dopamine release in the denervated striatum Neuroscience Letters 1989 96 3 329 334 (Pubitemid 19026702)
8. Hefti F., Enz A., Melamed E., Partial lesions of the nigrostriatal pathway in the rat. Acceleration of transmitter synthesis and release of surviving dopaminergic neurones by drugs Neuropharmacology 1985 24 1 19 23 (Pubitemid 15162487)
9. Zigmond M. J., Acheson A. L., Stachowiak M. K., Strickerm E. M., Neurochemical compensation after nigrostriatal bundle injury in an animal model of preclinical Parkinsonism Archives of Neurology 1984 41 8 856 861 (Pubitemid 14091728)
10. Zigmond M. J., Abercrombie E. D., Berger T. W., Grace A. A., Stricker E. M., Compensations after lesions of central dopaminergic neurons: some clinical and basic implications Trends in Neurosciences 1990 13 7 290 296 (Pubitemid 20193461)
11. Bustos G., Abarca J., Campusano J., Bustos V., Noriega V., Aliaga E., Functional interactions between somatodendritic dopamine release, glutamate receptors and brain-derived neurotrophic factor expression in mesencephalic structures of the brain Brain Research Reviews 2004 47 1-3 126 144 (Pubitemid 39574316)
12. Aliaga E., Crcamo C., Abarca J., Tapia-Arancibia L., Bustos G., Transient increase of brain derived neurotrophic factor mRNA expression in substantia nigra reticulata after partial lesion of the nigrostriatal dopaminergic pathway Molecular Brain Research 2000 79 1-2 150 155 (Pubitemid 30495538)
13. Bustos G., Abarca J., Bustos V., Riquelme E., Noriega V., Moya C., Campusano J., NMDA receptors mediate an early up-regulation of brain-derived neurotrophic factor expression in substantia nigra in a rat model of presymptomatic Parkinson's disease Journal of Neuroscience Research 2009 87 10 2308 2318
14. Altar C. A., Boylan C. B., Fritsche M., Jones B. E., Jackson C., Wiegand S. J., Lindsay R. M., Hyman C., Efficacy of brain-derived neurotrophic factor and neurotrophin-3 on neurochemical and behavioral deficits associated with partial nigrostriatal dopamine lesions Journal of Neurochemistry 1994 63 3 1021 1032 (Pubitemid 24266616)
15. Hyman C., Hofer M., Barde Y. A., Juhasz M., Yancopoulos G. D., Squinto S. P., Lindsay R. M., BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra Nature 1991 350 6315 230 232 (Pubitemid 21912205)
16. Tsukahara T., Takeda M., Shimohama S., Ohara O., Hashimoto N., Bakay R. A. E., Redmond D. E., Effects of brain-derived neurotrophic factor on 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-induced parkinsonism in monkeys Neurosurgery 1995 37 4 733 741
17. Von Bohlen Und Halbach O., Minichiello L., Unsicker K., Haploin-sufficiency for trkB and trkC receptors induces cell loss and accumulation of -synuclein in the substantia nigra FASEB Journal 2005 19 12 1740 1742 (Pubitemid 41429548)
18. Levivier M., Przedborski S., Bencsics C., Kang U. J., Intrastriatal implantation of fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevents degeneration of dopaminergic neurons in a rat model of Parkinson's disease Journal of Neuroscience 1995 15 12 7810 7820 (Pubitemid 26006890)
19. Porritt M. J., Batchelor P. E., Howells D. W., Inhibiting BDNF expression by antisense oligonucleotide infusion causes loss of nigral dopaminergic neurons Experimental Neurology 2005 192 1 226 234 (Pubitemid 40208556)
20. Baydyuk M., Nguyen M. T., Xu B., Chronic deprivation of TrkB signaling leads to selective late-onset nigrostriatal dopaminergic degeneration Experimental Neurology 2011 228 1 118 125
21. Canudas A. M., Pezzi S., Canals J. M., Palls M., Alberch J., Endogenous brain-derived neurotrophic factor protects dopaminergic nigral neurons against transneuronal degeneration induced by striatal excitotoxic injury Molecular Brain Research 2005 134 1 147 154 (Pubitemid 40403646)
22. Barbacid M., The Trk family of neurotrophin receptors Journal of Neurobiology 1994 25 11 1386 1403 (Pubitemid 24325064)
23. Dechant G., Molecular interactions between neurotrophin receptors Cell and Tissue Research 2001 305 2 229 238 (Pubitemid 32681899)
24. Lu B., Pang P. T., Woo N. H., The yin and yang of neurotrophin action Nature Reviews Neuroscience 2005 6 8 603 614 (Pubitemid 41059335)
25. Howells D. W., Porritt M. J., Wong J. Y. F., Batchelor P. E., Kalnins R., Hughes A. J., Donnan G. A., Reduced BDNF mRNA expression in the Parkinson's disease substantia nigra Experimental Neurology 2000 166 1 127 135
26. Nishio T., Furukawa S., Akiguchi I., Sunohara N., Medial nigral dopamine neurons have rich neurotrophin support in humans NeuroReport 1998 9 12 2847 2851 (Pubitemid 28435175)
27. Numan S., Seroogy K., Expression of trkB and trkC mRNAs by adult midbrain dopamine neurons: a double-label in situ hybridization study The Journal of Comparative Neurology 1999 403 295 308 (Pubitemid 29006214)
28. Seroogy K. B., Lundgren K. H., Tran T. M. D., Guthrie K. M., Isackson P. J., Gall C. M., Dopaminergic neurons in rat ventral midbrain express brain-derived neurotrophic factor and neurotrophin-3 mRNAs Journal of Comparative Neurology 1994 342 3 321 334 (Pubitemid 24105091)
29. Riquelme E., Abarca J., Bustos G., Ifenprodil, antagonist of NMDA-NR2B type glutamate receptors, blocks both the decrease in trkB expression and the disappearance of dopaminergic cells in SNc in a rat model of presymptomatic Parkinson's disease 1 Proceedings of the 18th Meeting of the Latinoamerican Society of Pharmacology 2008 Coquimbo, Chile 123
30. Paxinos G., Watson C., The Rat Brain in Stereotaxic Coordinates 1986 New York, NY, USA Acadenic Press
31. Andres M. E., Gysling K., Aravena S., Venegas A., Bustos G., NMDA-NR1 receptor subunit mRNA expression in rat brain after 6-OH-dopamine induced lesions: a non-isotopic in situ hybridization study Journal of Neuroscience Research 1996 46 375 384 (Pubitemid 26376372)
32. Marin C., Rodriguez-Oroz M. C., Obeso J. A., Motor complications in Parkinson's disease and the clinical significance of rotational behavior in the rat: have we wasted our time? Experimental Neurology 2006 197 2 269 274 (Pubitemid 43077134)
33. Dauer W., Przedborski S., Parkinson's disease: mechanisms and models Neuron 2003 39 6 889 909 (Pubitemid 37130207)
34. Sauer H., Oertel W. H., Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat Neuroscience 1994 59 2 401 415 (Pubitemid 24098798)
35. Shimohama S., Sawada H., Kitamura Y., Taniguchi T., Disease model: Parkinson's disease Trends in Molecular Medicine 2003 9 8 360 365 (Pubitemid 37040032)
36. Yan Q., Radeke M., Matheson C., Talvenheimo J., Welcher A., Feinstein S., Immunocytochemical localization of trkB in the central nervous system of the adult rat The Journal of Comparative Neurology 1997 378 135 157 (Pubitemid 27057536)
37. Zhou X. F., Parada L. F., Soppet D., Rush R. A., Distribution of trkB tyrosine kinase immunoreactivity in the rat central nervous system Brain Research 1993 622 1-2 63 70 (Pubitemid 23264948)
38. Arundine M., Tymianski M., Molecular mechanisms of calcium-dependent neurodegeneration in excitotoxicity Cell Calcium 2003 34 4-5 325 337 (Pubitemid 37021228)
39. Kish S. J., Shannak K., Hornykiewicz O., Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications New England Journal of Medicine 1988 318 14 876 880 (Pubitemid 18090271)
40. Ichitani Y., Okamura H., Nakahara D., Nagatsu I., Ibata Y., Biochemical and immunocytochemical changes induced by intrastriatal 6-hydroxydopamine injection in the rat nigrostriatal dopamine neuron system: evidence for cell death in the substantia nigra Experimental Neurology 1994 130 2 269 278
41. Przedborski S., Levivier M., Jiang H., Ferreira M., Jackson-Lewis V., Donaldson D., Togasaki D. M., Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine Neuroscience 1995 67 3 631 647
42. German D. C., Manaye K. F., Midbrain dopaminergic neurons (nuclei A8, A9, and A10): three-dimensional reconstruction in the rat Journal of Comparative Neurology 1993 331 3 297 309 (Pubitemid 23133526)
43. Riquelme E., Expresion en substantia nigra mesencefalica de trkB, receptor de BDNF, y su regulacion por receptores de glutamato tipo NMDA, frente a un dao progresivo de la via dopaminergica nigroestriatal. Posibles implicancias en relacion a la fase premotora y/o presintomatica de la enfermedad de Parkinson, Ph.D. thesis 2011 Santiago, Chile Facultad de Ciencias Biologicas, Pontificia Universidad Catolica de Chile
44. Frank L., BDNF down-regulates neurotrophin responsiveness, TrkB protein and TrkB mRNA levels in cultured rat hippocampal neurons European Journal of Neuroscience 1996 8 6 1220 1230 (Pubitemid 26174647)
45. Sommerfeld M. T., Schweigreiter R., Barde Y. A., Hoppe E., Down-regulation of the neurotrophin receptor TrkB following ligand binding. Evidence for an involvement of the proteasome and differential regulation of TrkA and TrkB Journal of Biological Chemistry 2000 275 12 8982 8990 (Pubitemid 30180257)
46. Gardoni F., Picconi B., Ghiglieri V., Polli F., Bagetta V., Bernardi G., Cattabeni F., Di Luca M., Calabresi P., A critical interaction between NR2B and MAGUK in L-DOPA induced dyskinesia Journal of Neuroscience 2006 26 11 2914 2922
47. Blandini F., Nappi G., Tassorelli C., Martignoni E., Functional changes of the basal ganglia circuitry in Parkinson's disease Progress in Neurobiology 2000 62 1 63 88 (Pubitemid 30252017)
48. Kingsbury T. J., Murray P. D., Bambrick L. L., Krueger B. K., Ca 2+ -dependent regulation of TrkB expression in neurons Journal of Biological Chemistry 2003 278 42 40744 40748 (Pubitemid 37280890)
49. Gogas K. R., Glutamate-based therapeutic approaches: NR2B receptor antagonists Current Opinion in Pharmacology 2006 6 1 68 74 (Pubitemid 43103821)
50. Hardingham G. E., Bading H., Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders Nature Reviews Neuroscience 2010 11 10 682 696
51. Loftis J. M., Janowsky A., The N-methyl-D-aspartate receptor subunit NR2B: localization, functional properties, regulation, and clinical implications Pharmacology and Therapeutics 2003 97 1 55 85 (Pubitemid 35477804)
52. Leon-Perez C., Efecto de K252A, antagonista del receptor del factor neurotrofico derivado de cerebro (BDNF), sobre la liberacion de glutamato, aspartato, acido gama aminobutrico y dopamina, en cuerpo estriado y substantia nigra de rata: estudios in vivo mediante la tecnica de microdalisis Memoria de Investigacion para optar al ttulo de Bioqumico 2006 Santiago, Chile Facultad de Ciencias Biologicas, Pontificia Universidad Catolica de Chile
53. Jang S. W., Liu X., Yepes M., Shepherd K. R., Miller G. W., Liu Y., Wilson W. D., Xiao G., Blanchi B., Sun Y. E., Ye K., A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone Proceedings of the National Academy of Sciences of the United States of America 2010 107 6 2687 2692
54. Mandel S. A., Sagi Y., Amit T., Rasagiline promotes regeneration of substantia nigra dopaminergic neurons in post-MPTP-induced parkinsonism via activation of tyrosine kinase receptor signaling pathway Neurochemical Research 2007 32 10 1694 1699 (Pubitemid 47428857)